Medical Device Approvals Through the Premarket Approval Pathway in Obstetrics and Gynecology From 2000 to 2015: Process and Problems.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Obstetrics and Gynecology

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/AOG.0000000000001430PMID 27159747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Developing Clinical Guidelines.

  2017cited by this paper
• Revisiting Essure—Toward Safe and Effective Sterilization

  2016cited by this paper
• Medical Device Postapproval Safety Monitoring: Where Does the United States Stand?

  2015cited by this paper
• The 21st Century Cures Act--Will It Take Us Back in Time?

  2015cited by this paper
• The 21st century cures act: Opportunities and challenges

  2015cited by this paper
• Transcatheter valve therapy registry is a model for medical device innovation and surveillance.

  2015cited by this paper
• Pivotal clinical trials of novel ophthalmic drugs and medical devices: retrospective observational study, 2002–2012

  2015cited by this paper
• Revisiting Essure--Toward Safe and Effective Sterilization.

  2015cited by this paper
• Regulatory reticence and medical devices.

  2014cited by this paper
• FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012.

  2014cited by this paper
• Long Tail Strings: Impact of the Dalkon Shield 40 Years Later

  2014cited by this paper
• The Food and Drug Administration Advisory Committees and Panels: How They Are Applied to the Drug Regulatory Process

  2014cited by this paper
• FDA considers restricting or banning laparoscopic morcellation.

  2014cited by this paper
• Medicolegal issues surrounding devices and mesh for surgical treatment of prolapse and incontinence.

  2013cited by this paper
• Regulation of medical devices in the United States and European Union.

  2012cited by this paper
• How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review

  2012cited by this paper
• Medical devices--balancing regulation and innovation.

  2012cited by this paper
• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years

  2011cited by this paper
• Medical devices--balancing regulation and innovation.

  2011cited by this paper
• Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers.

  2010cited by this paper
• Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review

  2010cited by this paper
• Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices.

  2009cited by this paper
• Developing clinical guidelines.

  1999cited by this paper
• Assessment of menstrual blood loss using a pictorial chart

  1990cited by this paper

• Late adverse event reporting from medical device manufacturers to the US Food and Drug Administration: cross sectional study

  2025cites this paper
• Safety reporting of Essure medical device: a qualitative and quantitative assessment on the FDA manufacturer and user facility device experience database in 2018

  2023cites this paper
• FDA Regulation and Approval of Medical Devices: 1976-2020.

  2021cites this paper
• A Comprehensive Analysis of Postmarket Surveillance Study Orders: Device Characteristics, Study Statuses, Outcomes, and Potential Contributions

  2020cites this paper
• Obstetrics and Gynecology

  2020cites this paper
• Reducing FDA regulations for medical devices: cutting red tape or putting patients’ lives at risk?

  2018cites this paper
• Medical-Legal Aspects of Transvaginal Mesh Kit Complications: A Historical Perspective and the US Food and Drug Administration Review Process

  2018cites this paper
• In Reply.

  2017cites this paper
• Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.

  2017cites this paper
• Regulatory Processes & Innovation Cycles in Times of Digitalization – a Contradiction?

  2017cites this paper
• Major FDA medical device recalls in ophthalmology from 2003 to 2015.

  2017cites this paper
• Device Safety Implications of the Clinical Data Leading to US Food and Drug Administration Approval of Soft-Tissue Fillers

  2017cites this paper
• Radiological Medical Device Innovation: Approvals via the Premarket Approval Pathway From 2000 to 2015.

  2017cites this paper
• Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.

  2017cites this paper
• Overview of high‐risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety

  2017cites this paper
• Oregon's Hard-Stop Policy Limiting Elective Early-Term Deliveries: Limitations of Before-and-After Studies in Evaluating Obstetric Policies.

  2017cites this paper
• Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study

  2016cites this paper